compare biomarket ltd
compare biomarket ltd Company Information
Company Number
10950109
Next Accounts
Sep 2025
Industry
Research and experimental development on biotechnology
Directors
Shareholders
alan john williams
Group Structure
View All
Contact
Registered Address
biomarket house nantwich road, crewe, cheshire, CW2 6NY
Website
talk-bio.comcompare biomarket ltd Estimated Valuation
Pomanda estimates the enterprise value of COMPARE BIOMARKET LTD at £131.1k based on a Turnover of £90.8k and 1.44x industry multiple (adjusted for size and gross margin).
compare biomarket ltd Estimated Valuation
Pomanda estimates the enterprise value of COMPARE BIOMARKET LTD at £0 based on an EBITDA of £-18.5k and a 5.11x industry multiple (adjusted for size and gross margin).
compare biomarket ltd Estimated Valuation
Pomanda estimates the enterprise value of COMPARE BIOMARKET LTD at £0 based on Net Assets of £-22k and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Compare Biomarket Ltd Overview
Compare Biomarket Ltd is a live company located in cheshire, CW2 6NY with a Companies House number of 10950109. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in September 2017, it's largest shareholder is alan john williams with a 100% stake. Compare Biomarket Ltd is a young, micro sized company, Pomanda has estimated its turnover at £90.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Compare Biomarket Ltd Health Check
Pomanda's financial health check has awarded Compare Biomarket Ltd a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 8 areas for improvement. Company Health Check FAQs
0 Strong
2 Regular
8 Weak
Size
annual sales of £90.8k, make it smaller than the average company (£4.1m)
- Compare Biomarket Ltd
£4.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -9%, show it is growing at a slower rate (13.9%)
- Compare Biomarket Ltd
13.9% - Industry AVG
Production
with a gross margin of 55%, this company has a comparable cost of product (55%)
- Compare Biomarket Ltd
55% - Industry AVG
Profitability
an operating margin of -21.4% make it less profitable than the average company (-8.5%)
- Compare Biomarket Ltd
-8.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (53)
1 - Compare Biomarket Ltd
53 - Industry AVG
Pay Structure
on an average salary of £83.2k, the company has an equivalent pay structure (£83.2k)
- Compare Biomarket Ltd
£83.2k - Industry AVG
Efficiency
resulting in sales per employee of £90.8k, this is less efficient (£131.1k)
- Compare Biomarket Ltd
£131.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Compare Biomarket Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 12 days, this is quicker than average (63 days)
- Compare Biomarket Ltd
63 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Compare Biomarket Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (33 weeks)
0 weeks - Compare Biomarket Ltd
33 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 632.9%, this is a higher level of debt than the average (52.1%)
632.9% - Compare Biomarket Ltd
52.1% - Industry AVG
COMPARE BIOMARKET LTD financials
Compare Biomarket Ltd's latest turnover from December 2023 is estimated at £90.8 thousand and the company has net assets of -£22 thousand. According to their latest financial statements, Compare Biomarket Ltd has 1 employee and maintains cash reserves of £293 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 3,830 | 2,487 | 2,481 | 373 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 3,830 | 2,487 | 2,481 | 373 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 8,878 | 0 | 0 | 0 | 2,400 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 216 | 1,715 | 39 | 0 | 0 |
| Cash | 293 | 2,794 | 351 | 16,561 | 4,872 | 1,024 |
| misc current assets | 0 | 0 | 0 | 0 | 5,321 | 0 |
| total current assets | 293 | 11,888 | 2,066 | 16,600 | 10,193 | 3,424 |
| total assets | 4,123 | 14,375 | 4,547 | 16,973 | 10,193 | 3,424 |
| Bank overdraft | 341 | 0 | 9,306 | 0 | 327 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,440 | 72 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 24,313 | 16,910 | 2,292 | 9,399 | 8,947 | 8,514 |
| total current liabilities | 26,094 | 16,982 | 11,598 | 9,399 | 9,274 | 8,514 |
| loans | 0 | 0 | 0 | 246 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 246 | 0 | 0 |
| total liabilities | 26,094 | 16,982 | 11,598 | 9,645 | 9,274 | 8,514 |
| net assets | -21,971 | -2,607 | -7,051 | 7,328 | 919 | -5,090 |
| total shareholders funds | -21,971 | -2,607 | -7,051 | 7,328 | 919 | -5,090 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 957 | 621 | 643 | 93 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -9,094 | 7,379 | 1,676 | 39 | -2,400 | 2,400 |
| Creditors | 1,368 | 72 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 7,403 | 14,618 | -7,107 | 452 | 433 | 8,514 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | -246 | 246 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -2,501 | 2,443 | -16,210 | 11,689 | 3,848 | 1,024 |
| overdraft | 341 | -9,306 | 9,306 | -327 | 327 | 0 |
| change in cash | -2,842 | 11,749 | -25,516 | 12,016 | 3,521 | 1,024 |
compare biomarket ltd Credit Report and Business Information
Compare Biomarket Ltd Competitor Analysis
Perform a competitor analysis for compare biomarket ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in CW2 area or any other competitors across 12 key performance metrics.
compare biomarket ltd Ownership
COMPARE BIOMARKET LTD group structure
Compare Biomarket Ltd has no subsidiary companies.
Ultimate parent company
COMPARE BIOMARKET LTD
10950109
compare biomarket ltd directors
Compare Biomarket Ltd currently has 1 director, Mr Alan Williams serving since Sep 2017.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Alan Williams | England | 48 years | Sep 2017 | - | Director |
P&L
December 2023turnover
90.8k
+11%
operating profit
-19.4k
0%
gross margin
55%
+2.09%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-22k
+7.43%
total assets
4.1k
-0.71%
cash
293
-0.9%
net assets
Total assets minus all liabilities
Similar Companies
compare biomarket ltd company details
company number
10950109
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
September 2017
age
7
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
talk biotech ltd (August 2023)
accountant
-
auditor
-
address
biomarket house nantwich road, crewe, cheshire, CW2 6NY
Bank
-
Legal Advisor
-
compare biomarket ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to compare biomarket ltd.
compare biomarket ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for COMPARE BIOMARKET LTD. This can take several minutes, an email will notify you when this has completed.
compare biomarket ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
